RxDoctor Payments Data

Barbara Stjohn

Primary Care · Wellesley, MANPI 1275886285

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 34.7% of the total. Reporting peaked in 2021 at $661 and has fallen 59.0% since, to $271 in 2025. Among primary care clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,929in general payments, 2019–2025

Across 62 payments — averaging $31.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$669
  • Galderma Laboratories, L.p.$338
  • Lilly USA, LLC$227
  • LEO Pharma Inc.$202
  • Regeneron Healthcare Solutions, Inc.$159
  • Sun Pharmaceutical Industries Inc.$141
  • plus $193 from 5 others

What the payments were for

  • Food & beverage$1,929100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,929 in reported general payments places this provider in the 90th percentile of 181 primary care providers in Massachusetts.

See all primary care providers in Massachusetts

Medicare billing

Part B allowed, 2024
$26,876
Medicare patients
105
Services billed
472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate18$1,697
Ketoconazole20$332
Triamcinolone Acetonide21$296
Hydrocortisone11$49

Paid to pharmacies, not to this prescriber.

Other primary care in Wellesley

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →